Print PDF

Formation of Worldwide Research Consortium

Represented a contract research organization in the formation of a worldwide research consortium comprised of universities and academic research organizations focused on research and clinical trials involving new and experimental drug therapies to treat pancreatic cancer. This intentionally flexible agreement initially involved several prominent institutions. It has since been translated into multiple languages and over a dozen new members have signed on to the agreement and joined the consortium, all without substantive changes to the original agreement.
Jump to Page

How Can We
Help You?

By using this site, you agree to our updated Privacy Policy and our Terms of Use.